跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
DeVital Mobiease Capsule - NPRA Drug Approval Details
Approvals
/
NPRA
/
DeVital Mobiease Capsule
Approved
STANDARD
DeVital Mobiease Capsule
SUPERB PHARMA SDN. BHD.
🇲🇾 National Pharmaceutical Regulatory Agency
Approval Date
Nov 29, 2025
Approval ID
d1e13a1b73537aa7
Company
SUPERB PHARMA SDN. BHD.
Type
Standard
Approval Details
Approval Id
d1e13a1b73537aa7
Drug Approval Npra Name
DeVital Mobiease Capsule
Product Name
DeVital Mobiease Capsule
Registration Number
MAL25076048NC
Holder Company Name
SUPERB PHARMA SDN. BHD.
Holder Address
NO 20, JALAN TPP 16, TAMAN PERINDUSTRIAN PUTRA 47130 PUCHONG MALAYSIA
Holder Phone
0162059185
Manufacturer Company Name
Esprit Care Sdn. Bhd.
Manufacturer Address
NO. 61, 65, 67 & 69, JALAN TPP 1/13 TAMAN PERINDUSTRIAN PUCHONG, BATU 12 47100 PUCHONG MALAYSIA
Source Url
https://quest3plus.bpfk.gov.my/pmo2/detail.php?type=product&id=MAL25076048NC
Version
1764410737
Active Ingredients
Approved
Quick Info
Agency
NPRA
Country
🇲🇾
Approval Date
Nov 29, 2025
Approval ID
d1e13a1b73537aa7
Type
Standard
Source
Official Source
Back to NPRA Approvals